Medical/Pharmaceuticals
Medicilon and Hengrui Pharma Deepen Strategic Collaboration to Support Innovation in ADCs, Small Nucleic Acids, and CGT Drugs
BOSTON, July 31, 2024 /PRNewswire/ -- Recently, Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.The cooperative efforts will focus on preclinical evaluation of new drug modalities, particularly ADCs...
2024-07-31 22:39
2313
SURGLASSES Announces Successful First Clinical Implementation of Caduceus S AR Surgical Navigation System in Thailand
ONTARIO, Calif., July 31, 2024 /PRNewswire/ -- Leading augmented reality (AR) medical technology company SURGLASSES today announced that, in collaboration with exclusive distributor Goodlifeintertrade.co. Ltd., it has successfully registered and clinically implemented its AR-based Caduceus S surg...
2024-07-31 21:00
3753
PROCESSED RED MEAT RAISES THE RISK OF DEMENTIA; SWAPPING IT FOR NUTS AND BEANS MAY LOWER RISK
Four-decade study of more than 130,000 people measured the risk of your morning bacon or ballgame hot dog Key Takeaways * Eating about two servings per week of processed red meat raises the risk of dementia by 14% compared to those who eat less than approximately three servings a month. * S...
2024-07-31 19:00
2793
Kexing Biopharm's Albumin-bound Paclitaxel Granted EU Market Approval
SHENZHEN, China, July 31, 2024 /PRNewswire/ -- On July 28 2024, Kexing Biopharm announced European Commission approval of Apexelsin®, the generic drug to Bristol Myers Squibb's and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed by WhiteOak Pharmaceutical B.V. and Kexing Biopharm is ...
2024-07-31 18:33
3479
JelloX Biotech collaborates with Mayo Clinic to develop AI enhanced 3D pathology imaging technology
HSINCHU, July 31, 2024 /PRNewswire/ -- JelloX Biotech Inc. ('JelloX') is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to further develop and validate their 3D digital imaging and AI analysis technology. JelloX previously participated i...
2024-07-31 17:00
1985
Fapon Delivers Customized IVD Solutions for the US Market at ADLM 2024
CHICAGO, July 31, 2024 /PRNewswire/ -- Fapon, a global leading life sciences company, is showcasing its innovative IVD total solutions at ADLM 2024 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), fromJuly 28 to August 1 in Chicago. Committed to supporting local partners, we del...
2024-07-31 14:42
1898
FDA Grants Orphan Drug Designation (ODD) Status to Zymedi's ZMA001 for Pulmonary Arterial Hypertension
INCHEON, South Korea, July 30, 2024 /PRNewswire/ -- Zymedi (CEO Sunghoon Kim) announced that its first-in-class antibody treatment ZMA001, currently in development for pulmonary arterial hypertension (PAH), has been designated as an Orphan Drug by the U.S. Food and Drug Administration (FDA). Pul...
2024-07-31 08:00
2268
Porton Advanced and Geneseed Biotech Enter into Strategic Collaboration to Focus on Advancing circRNA Innovative Therapeutics
SUZHOU, China, July 30, 2024 /PRNewswire/ -- On July 29, 2024, Porton Advanced Solutions ("Porton Advanced") announced that it had reached a strategic cooperation with Guangzhou Geneseed Biotech Co., Ltd ("Geneseed Biotech"). Both sides will combine their respective strengths in the field of gene...
2024-07-30 22:00
3384
Connext Successfully Administers First Dose of CNT201 for Dupuytren's Contracture
World's First Genetically Recombinant Collagenase Therapeutics (CNT201) Begins Clinical Trials inAustralia SEOUL, South Korea, July 30, 2024 /PRNewswire/ -- Connext has announced the successful first administration of CNT201, its therapeutic treatment for Dupuytren's contracture, in patients. D...
2024-07-30 21:00
2888
Sengenics Corporation Unveils i-Ome® Cancer: A Breakthrough in Cancer Precision Medicine
Revolutionizing Biomarker Discovery with a High-Throughput Immunoproteomic Platform BOSTON, July 30, 2024 /PRNewswire/ -- Sengenics Corporation LLC is proud to announce the launch of i-Ome Cancer, a cutting-edge research tool designed to transform cancer biomarker discovery using just a drop of ...
2024-07-30 20:30
2790
GLP-1 DRUG LIRAGLUTIDE MAY PROTECT AGAINST DEMENTIA
Key Takeaways * A GLP-1 agonist — the class of drugs shown to help with diabetes and weight loss and reduce the risk of heart disease — also may protect the brain. * In a Phase 2b trial, liraglutide appears to reduce shrinking in the parts of the brain that control memory, learning, language ...
2024-07-30 19:00
2984
Baird Medical Announces Engagement and Education Program for the Development of Thyroid Microwave Ablation Technology
FRISCO, Texas, July 30, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical"), a leading developer and provider of microwave ablation ("MWA") medical devices inChina and the United States, today announced a cross-market engagement and education program designed at fostering both kno...
2024-07-30 17:00
2266
Clarivate Introduces New OFF-X ™ Platform for Preclinical and Clinical Safety Intelligence
Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages LONDON, July 30, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the newOFF-X™ platform. The enhance...
2024-07-30 15:00
2320
Synthetica Pioneering Closes a Series A Funding Round to Support Development of Oncolytic Bacterial Therapy for Solid Tumors
SHENZHEN, China, July 30, 2024 /PRNewswire/ -- Shenzhen Synthetica Pioneering Co., Ltd. (Synthetica), a biotech startup specializing in synthetic biology for engineering novel living bacterial therapeutics, has recently closed a Series A funding round, led by Boehringer Ingelheim Venture Fund and...
2024-07-30 14:00
2310
Baxter's Helion System Launches in Thailand, Bringing Comprehensive Simplicity to ORs
BANGKOK, July 30, 2024 /PRNewswire/ -- Baxter International Inc
2024-07-30 10:23
3581
NCCN and Medlive Renew Collaboration to Enhance Cancer Care in China
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncology guidelines inChina PLYMOUTH MEETING, Pa., July 30, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®), an alliance o...
2024-07-30 09:02
2839
NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION ON SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH NEUROGENETIC DISORDERS (NGDs)
TEL-AVIV, Israel, July 30, 2024 /PRNewswire/ -- Neurim Pharmaceuticals
2024-07-30 09:00
4017
Bridge Biotherapeutics Announces Completion of Enrollment in the Phase 2a Clinical Study of BBT-877 for the Treatment of Idiopathic Pulmonary Fibrosis
SEONGNAM, South Korea, July 29, 2024 /PRNewswire/ -- Bridge Biotherapeutics (KQ288330), a clinical-stage biotech company based inSouth Korea developing novel drugs for fibrosis and cancer, today announced that patient participant enrollment has been completed in the Phase 2 clinical study of BBT-...
2024-07-30 06:00
2212
CSafe launches reusable Silverpod pallet shipper to help pharma companies save on disposal costs and hit sustainability targets
New pallet improves cost and operational efficiency while reducing environmental impact; includes real-time visibility with cloud connectivity Key features include: * Made of fully reusable components and recyclable PCM (phase change material) refrigerants * New integrated real-time tracking...
2024-07-30 02:00
2979
Menarini Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Efficacy, Safety and Tolerability of Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia
-- Achieved primary endpoint of LS mean reduction in LDL-C on top of maximally tolerated lipid modifying therapies at week 12 with statistically significant reduction (p<0.0001), which was sustained at week 52 (p<0.0001) -- -- Obicetrapib lowered LDL-C by 36.3% at week 12 and by 41.5% at week 52,...
2024-07-29 23:18
3266
Week's Top Stories
Most Reposted
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show
[Picked up by 328 media titles]
2026-02-19 14:30
NextFin Asia: A New Dedicated Fund for the Catapult: Inclusion SE Asia Program to Further Scale Inclusive Finance Fintechs in ASEAN
[Picked up by 311 media titles]
2026-02-23 08:00
Vitafoods Asia 2026 Expands by 30%: A Bigger, More Dynamic Trade Event with Exciting New Features & Increased International Participation
[Picked up by 287 media titles]
2026-02-23 10:09
Little Artists Art Studio, Singapore Shines at Art Capital 2026
[Picked up by 280 media titles]
2026-02-17 19:12
Kung Fu Meets Spring -- Unitree Spring Festival Gala Robots Present "Cyber Real Kung Fu" in the Year of the Horse
[Picked up by 260 media titles]
2026-02-17 14:16